AMNIOCENTESIS NEEDLES MARKET ANALYSIS

Amniocentesis Needles Market, By Product Type (100mm to 150mm, Smaller Than 100 mm, and Larger Than 150 mm), By Application (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion, and Cordocentesis) By End User (Hospitals, Diagnostic Centers, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published In : May 2019
Code : CMI2624
Pages :166
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Amniocentesis Needles Market - Restraints

The major restraining factor for the global amniocentesis needles market growth is availability of alternative tests for the amniocentesis. The alternatives tests include Non-Invasive Prenatal Test (NIPT), first trimester combined screening, second trimester quad screen, and integrated screening. Increasing adoption of NIPT by patients is hampering the global amniocentesis needle market as the NIPT is associated with less incision, less pain, and quick healing. According to the data published in Clinical Chemistry Journal in 2017, several U.S. and global clinical laboratories have licensed the needed intellectual property to allow for NIPT to be implemented in as many as 15 U.S. laboratories by the end of 2017. In the U.S. nearly 3000 women were screened, while testing was offered at no charge to the patient in 2017.